← FDA DRUG APPROVALS

FDA ANDA · ANDA073552

BETAMETHASONE DIPROPIONATE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA073552
TYPE
ANDA
ORIGINAL APPROVAL
1992-04-30
LATEST ACTION
2017-05-26
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

BETAMETHASONE DIPROPIONATEPrescription
BETAMETHASONE DIPROPIONATE EQ 0.05% BASE · CREAM · TOPICAL

Approval history

2017-05-26Labeling · Supplement 12 · standardAP
1997-09-15Manufacturing (CMC) · Supplement 3AP
1997-09-15Manufacturing (CMC) · Supplement 4AP
1996-09-17Manufacturing (CMC) · Supplement 2AP
1996-05-06Manufacturing (CMC) · Supplement 1AP
1992-04-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →